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Drainage developers
O
ur bodies’ tissues need contin-
uous irrigation and drainage. 
Blood vessels feeding the tis-
sues bring in the fl  uids, and drainage 
occurs via the lymphatic system. Where-
as much is known about how blood ves-
sels are built, the same was not true for 
lymph vessels. Now though, Norrmén et 
al. have identifi  ed two of the lead engi-
neers that direct drainage construc-
tion—the transcription factors, Foxc2 
and NFATc1 (1). 
Previous studies found that mice 
lacking Foxc2 have malformed lymph 
vessels (2). Also, people with mutated 
Foxc2 suffer from severe limb swelling 
(lymphedema-distichiasis) caused by 
poor lymph drainage (3). Norrmén and 
colleagues have now found that Foxc2 
specifi   cally regulates a late stage of 
lymph development when large, valve-
containing vessels arise from more 
primitive capillaries.
One characteristic of the mal-
formed vessels in Foxc2-defi  cient mice 
is a lack of valves. “At the moment 
nothing is known [about] how lymphat-
ic valves develop,” explained Tatiana 
Petrova, who led the 
study. The team there-
fore turned to proteins 
known to build heart 
valves to look for can-
didates that might co-
operate with Foxc2 in 
the lymphatic system.
Only one of these 
candidates, NFATc1, 
showed expression in 
the developing lymph 
system of normal mice, 
and the factor was 
particularly abundant 
in lymph vessel valves. Mice lacking 
NFATc1 die at an embryonic stage be-
fore lymph valve formation—presum-
ably due to failure of their heart and 
blood vessels, which develop earlier 
than the lymphatic system. To investi-
gate the effect of NFATc1 on lymphatic 
valve development, the authors waited 
for normal mouse embryos to develop 
their circulatory system and then treated 
them with an NFAT inhibitor. The effect 
was very similar to that of mice that 
lack Foxc2. Supporting evidence for 
NFATc1’s involvement in lymph vessel 
development was published recently by 
a second group (4).
Norrmén and colleagues went further 
to show that Foxc2 and NFATc1 physically 
interact and that many 
DNA binding sites for 
the two transcription fac-
tors are closely linked. 
This latter discovery arose 
from a genome-wide 
search for Foxc2 bind-
ing sites and was some-
what of a nice surprise, 
according to Petrova. 
“We gave the Foxc2 data 
to bioinformaticians in 
Lausanne and they said, 
‘Well you know there 
are NFAT binding sites 
highly enriched in your Foxc2 data’ and I 
think that was the most pleasant moment, 
actually, because they didn’t know any-
thing about this NFAT stuff, and they just 
came independently saying, ‘Well it seems 
they might interact.’”
The bioinformaticians also came 
up with a consensus binding site for 
Foxc2, and a long list of target loci that 
might be controlled by the two transcrip-
tion factors. The team now plans to in-
vestigate these targets as well as to work 
out the upstream molecular pathways 
controlling Foxc2 and NFATc1. It ap-
pears that the two factors are controlled 
by independent pathways—defi  ciency of 
one does not affect the other—and so it’s 
likely that they work synergistically to 
promote target gene expression.
Whatever the mechanism, if they 
can show that Foxc2 and NFATc1 also 
prompt lymph vessel regeneration in 
adults, boosting these factors could 
help patients with lymph drainage prob-
lems—including those that have suf-
fered extensive tissue injuries, or have 
had lymph nodes removed as part of 
cancer treatment.
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(L-R) Camilla Norrmén (lead author) and Tatiana Petrova (senior author). Normal valve-
containing lymph vessels (left) fail to form in mice that lack Foxc2 and NFATc1 (right). The 
study by Norrmén et al. suggests that these two transcription factors direct the building of 
mature lymph-collecting vessels by coming together to regulate target gene loci.
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Researchers identify interacting engineers of the body’s lymphatic drainage system.
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